Quick Answer
TELA Bio, Inc. reported Diluted EPS of $0.83 per share (loss) for fiscal year 2025.
TELA Bio, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.83 | +37.6% |
| 2024 | -$1.33 | +34.8% |
| 2023 | -$2.04 | +25.0% |
| 2022 | -$2.72 | -18.3% |
| 2021 | -$2.30 | -3.1% |
| 2020 | -$2.23 | +87.0% |
| 2019 | -$17.10 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.19 | +54.8% | +13.6% |
| June 30, 2025 | -$0.22 | +56.9% | +12.0% |
| March 31, 2025 | -$0.25 | -8.7% | +40.5% |
| September 30, 2024 | -$0.42 | +6.7% | +17.6% |
| June 30, 2024 | -$0.51 | -10.9% | -121.7% |
| March 31, 2024 | -$0.23 | +63.5% | +48.9% |
| September 30, 2023 | -$0.45 | +29.7% | +2.2% |
| June 30, 2023 | -$0.46 | +47.7% | +27.0% |
- TELA Bio, Inc. showed an increase of +37.6% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, TELA Bio, Inc.’s diluted eps has grown by 95.1% (from $17.10 per share (loss) to $0.83 per share (loss)).
- The most recent figure is from TELA Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: